SCHEMBL845160

SCHEMBL845160

O=C(Cc1ccccc1)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)Cc3ccccc3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.53
ALDH1A1 P00352 2/20 0.53
KDM4E B2RXH2 2/20 0.49
MAPT P10636 1/20 0.49
NR4A1 P22736 1/20 0.49
ITGB1 P05556 4/20 0.49
ITGA4 P13612 4/20 0.49
LMNA P02545 1/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSD17B10 Q99714 1/20 0.48
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MCL1 Q07820 1/20 0.47
HCRTR1 O43613 2/20 0.47
HCRTR2 O43614 2/20 0.47
KDM1A O60341 1/20 0.47
RCOR1 Q9UKL0 1/20 0.47
PABPC1 P11940 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845226 0.96 ALDH1A1 (0.56) ALDH1A1KDM4EITGB1ITGA4LMNA
SCHEMBL845111 0.96 ALDH1A1 (0.56) ALDH1A1KDM4EITGB1ITGA4LMNA
SCHEMBL1030175 0.96 ALDH1A1 (0.56) ALDH1A1KDM4EITGB1ITGA4LMNA
SCHEMBL13272444 0.96 ALDH1A1 (0.56) ALDH1A1KDM4EITGB1ITGA4LMNA
SCHEMBL845205 0.96 ALDH1A1 (0.56) ALDH1A1KDM4EITGB1ITGA4LMNA
SCHEMBL15116912 0.96 ALDH1A1 (0.56) ALDH1A1KDM4EITGB1ITGA4LMNA
SCHEMBL845657 0.94 ALDH1A1 (0.52) HSD11B1ALDH1A1KDM4EITGB1ITGA4
SCHEMBL845712 0.92 HRH3 (0.50) HSD11B1ALDH1A1KDM4EMAPTNR4A1
SCHEMBL845171 0.92 ALDH1A1 (0.53) ALDH1A1KDM4EITGB1ITGA4LMNA
SCHEMBL845154 0.91 ALDH1A1 (0.54) ALDH1A1KDM4EITGB1ITGA4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed